Some fitness trackers may detect signs of heart disease, sleep problems, and chronic stress. However, there are limitations ...
Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Overall, the study demonstrates that an AI-enabled hub-and-spoke model can significantly improve the speed and efficiency of ...
As Vietnam advances national digital health initiatives, connected diagnostic tools are becoming increasingly important. Kardia 12L now strengthens AliveCor's cardiovascular portfolio by standing ...
Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.
Once submitted, the ECG is evaluated within 24 hours by a Canadian-registered cardiologist from WELL Health's network. Each review provides a more comprehensive clinical evaluation to confirm or ...
AI platform recognized for real-world clinical impact through analysis of raw 12-lead ECG data, enabling earlier detection of multiple cardiovascular diseasesNEW ORLEANS, March 29, 2026 (GLOBE ...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized ...
Real-world evidence to be presented at the American College of Cardiology Scientific Session 2026 highlights impact of Viz HCM, developed as part of a multi-year agreement with Bristol Myers Squibb, ...
HeartBeam, Inc. (BEAT) (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results